Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL)...

FDA Drug Recall #D-1494-2020 — Class II — August 4, 2020

Recall Summary

Recall Number D-1494-2020
Classification Class II — Moderate risk
Date Initiated August 4, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Location Greenville, SC
Product Type Drugs
Quantity 7416 bottles

Product Description

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16

Reason for Recall

Subpotent drug: Out of specification for assay at the 15-month test interval.

Distribution Pattern

Nationwide USA

Lot / Code Information

Lot: B973, Exp 11/20

Other Recalls from PAI Holdings, LLC. dba Pharmaceutical...

Recall # Classification Product Date
D-0222-2025 Class III Guaifenesin and Codeine Phosphate Oral Solution... Jan 7, 2025
D-0723-2021 Class II Ethosuximide Oral Solution USP 250 mg/5 mL, 16 ... Jul 29, 2021
D-0722-2021 Class II Cimetidine Hydrochloride Oral Solution 300 mg/5... Jul 29, 2021
D-0721-2021 Class II Nystatin Oral Suspension, USP 100,000 units per... Jul 29, 2021
D-0015-2021 Class III Citalopram Oral Solution, USP 20 mg/10 mL, 10 m... Sep 9, 2020

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.